---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-023189"
form_type: "8-K"
ticker: "TOI"
cik: "0001799191"
company_name: "Oncology Institute, Inc."
filed_at: "2024-05-14T23:59:59+00:00"
generated_at: "2026-06-02T01:06:15.283378+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Oncology Institute Q1 revenue up 24% to $95M; net loss narrows to $19.9M

## Summary
- Revenue of $95M (+24.2% YoY); net loss $19.9M vs $30.0M loss in prior year.
- Gross profit $12M (-15.1% YoY); gross margin 12.6% vs 18.5% a year ago.
- Adjusted EBITDA loss of $10.9M vs $7.4M loss in prior year quarter.
- Signed 7 new value-based contracts; reaffirmed full-year 2024 guidance.
- Ended Q1 with 73 clinics, 126 providers; scripts dispensed up 70% YoY.

## SEC filing metadata
- accession: 0001628280-24-023189
- form_type: 8-K
- ticker: TOI
- cik: 0001799191
- company_name: Oncology Institute, Inc.
- filed_at: 2024-05-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799191/000162828024023189/0001628280-24-023189-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799191/000162828024023189/toi-20240514.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-023189
- JSON: https://secwatch.observer/filing/0001628280-24-023189.json
- Plain text: https://secwatch.observer/filing/0001628280-24-023189.txt

## Key facts
- Earnings Releases
  Oncology Institute, Inc. reported three months ended March 31, 2024 results: revenue $95 million, net income Net loss of $19.9 million, EPS $(0.22) and $(0.22). Guidance reaffirmed.
  - Period: three months ended March 31, 2024
  - Revenue: $95 million
  - Net income: Net loss of $19.9 million
  - EPS: $(0.22) and $(0.22)
  - Guidance: reaffirmed
  - Result: reported results
  source text: Officer • Hired 7 new providers in the quarter and ended the quarter with 73 clinics and 126 employed providers First Quarter 2024 Financial Highlights • Consolidated revenue of $95 million, an increase of 24.2% from $76 million compared to the prior year quarter • Gross profit of $12 million, a decrease of 15.1% compared to the prior year quarter, and gross margin
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799191/000162828024023189/0001628280-24-023189-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.